{"title":"维生素D在人早幼粒细胞白血病细胞(HL-60)中的代谢II。细胞的分化会改变新陈代谢吗?","authors":"Y Imae, M Shimizu, C Miyaura, T Suda, S Yamada","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The metabolism of 25-hydroxyvitamin D3 (25-OH-D3) in human promyelocytic leukemia cells (HL-60) which had been exposed to 1 alpha, 25-dihydroxyvitamin D3 (1,25-(OH)2D3) was compared with that in untreated cells. 8 alpha, 25-Dihydroxy-9,10-seco-4,6,10(19)-cholestatrien-3-one (8,25-(OH)2-3-oxoneo-D3) was the only major metabolite in untreated HL-60 cells but exposure of the cells to 1,25-(OH)2D3 for 1 day significantly changed the metabolism: 24R,25-dihydroxyvitamin D3 (24R,25-(OH)2D3) was produced as the major metabolite together with 8,25-(OH)2-3-oxoneo-D3 whose production was also increased. The 1,25-(OH)2D3 treatment did not stimulate the production of 25-hydroxyvitamin D3 26,23-lactone by the HL-60 cells. The metabolism of 25-OH-D3 by HL-60 cells was also significantly affected by fetal bovine serum added to the incubation medium: production of 24R,25-(OH)2D3 was significantly reduced and formation of 8,25-(OH)2-3-oxoneo-D3 was completely abolished.</p>","PeriodicalId":75958,"journal":{"name":"Iyo Kizai Kenkyujo hokoku. Reports of the Institute for Medical and Dental Engineering, Tokyo Medical and Dental University","volume":"23 ","pages":"73-80"},"PeriodicalIF":0.0000,"publicationDate":"1989-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Metabolism of vitamin D in human promyelocytic leukemia cells (HL-60) II. Does the differentiation of the cells alter the metabolism?\",\"authors\":\"Y Imae, M Shimizu, C Miyaura, T Suda, S Yamada\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The metabolism of 25-hydroxyvitamin D3 (25-OH-D3) in human promyelocytic leukemia cells (HL-60) which had been exposed to 1 alpha, 25-dihydroxyvitamin D3 (1,25-(OH)2D3) was compared with that in untreated cells. 8 alpha, 25-Dihydroxy-9,10-seco-4,6,10(19)-cholestatrien-3-one (8,25-(OH)2-3-oxoneo-D3) was the only major metabolite in untreated HL-60 cells but exposure of the cells to 1,25-(OH)2D3 for 1 day significantly changed the metabolism: 24R,25-dihydroxyvitamin D3 (24R,25-(OH)2D3) was produced as the major metabolite together with 8,25-(OH)2-3-oxoneo-D3 whose production was also increased. The 1,25-(OH)2D3 treatment did not stimulate the production of 25-hydroxyvitamin D3 26,23-lactone by the HL-60 cells. The metabolism of 25-OH-D3 by HL-60 cells was also significantly affected by fetal bovine serum added to the incubation medium: production of 24R,25-(OH)2D3 was significantly reduced and formation of 8,25-(OH)2-3-oxoneo-D3 was completely abolished.</p>\",\"PeriodicalId\":75958,\"journal\":{\"name\":\"Iyo Kizai Kenkyujo hokoku. Reports of the Institute for Medical and Dental Engineering, Tokyo Medical and Dental University\",\"volume\":\"23 \",\"pages\":\"73-80\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1989-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Iyo Kizai Kenkyujo hokoku. Reports of the Institute for Medical and Dental Engineering, Tokyo Medical and Dental University\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iyo Kizai Kenkyujo hokoku. Reports of the Institute for Medical and Dental Engineering, Tokyo Medical and Dental University","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Metabolism of vitamin D in human promyelocytic leukemia cells (HL-60) II. Does the differentiation of the cells alter the metabolism?
The metabolism of 25-hydroxyvitamin D3 (25-OH-D3) in human promyelocytic leukemia cells (HL-60) which had been exposed to 1 alpha, 25-dihydroxyvitamin D3 (1,25-(OH)2D3) was compared with that in untreated cells. 8 alpha, 25-Dihydroxy-9,10-seco-4,6,10(19)-cholestatrien-3-one (8,25-(OH)2-3-oxoneo-D3) was the only major metabolite in untreated HL-60 cells but exposure of the cells to 1,25-(OH)2D3 for 1 day significantly changed the metabolism: 24R,25-dihydroxyvitamin D3 (24R,25-(OH)2D3) was produced as the major metabolite together with 8,25-(OH)2-3-oxoneo-D3 whose production was also increased. The 1,25-(OH)2D3 treatment did not stimulate the production of 25-hydroxyvitamin D3 26,23-lactone by the HL-60 cells. The metabolism of 25-OH-D3 by HL-60 cells was also significantly affected by fetal bovine serum added to the incubation medium: production of 24R,25-(OH)2D3 was significantly reduced and formation of 8,25-(OH)2-3-oxoneo-D3 was completely abolished.